To study the effect of PIM inhibition on AML cell growth, we treated 6 cell lines expressing PIM1 or PIM2 for 5 days with AZD1208 and measured viability (Figure 1A and S1A). The gene discussed is PIM2; the disease is acute myeloid leukemia.